Opus Genetics IRD
NASDAQ IRD
$3.95 -0.16 (-4.01%)
As of: Oct 22, 2026 · 10:28 AM EDT

Opus Genetics (IRD) Short-Term Debt repayments (2021 - 2022)

Updated

Opus Genetics (IRD) posted Short-Term Debt repayments of $538,000 for FY2022, up 398.1% from $108,000 in FY2021.

Analysis

Opus Genetics (IRD) Short-Term Debt repayments (2021 - 2022) Analysis & Trends

  • Business Quant data shows IRD's Short-Term Debt repayments at $108,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,164.36 Bn 1,132.95 Bn 19.71 Bn -
2 Johnson & Johnson 634.54 Bn 553.07 Bn 17.26 Bn 6.45 Bn
3 AbbVie 502.85 Bn 475.96 Bn 12.70 Bn -
4 Merck 376.50 Bn 330.88 Bn 12.21 Bn -
5 Novartis Ag 303.65 Bn 267.64 Bn 11.24 Bn -
6 Astrazeneca 266.62 Bn 240.30 Bn 12.86 Bn -
7 Amgen 241.17 Bn 196.57 Bn 7.24 Bn -
8 Gilead Sciences 193.39 Bn 167.59 Bn 6.22 Bn -
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Opus Genetics 377.16 Mn 152.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 215,000.00
Mar 31, 2022 323,000.00
Dec 31, 2021 108,000.00
API Access

Opus Genetics Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=IRD&period=max&api_key=YOUR_API_KEY